Synnovation Therapeutics, a precision oncology startup based out of the Experimental Station in Wilmington has emerged with $102 million financing last week.
© 2024 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.